{
    "Question": "RetinaScope BV CES 2024 product highlight and specification",
    "Summary": "RetinaScope BV\n\nProduct: RetinaScope Plus\n\n- A low-cost, handheld fundus camera designed for better screening of eye diseases, particularly for diabetic retinopathy, age-related macular degeneration (AMD), and glaucoma.\n- Founded in 2018 as a spin-out of the Dutch Value Added Distribution company IDCP BV, RetinaScope BV aims to provide earlier and more frequent screening for eye diseases by shifting fundus imaging for diabetic patients from specialists to general practitioners, optometrists, and opticians.\n- The company received investment from TNO and the Innovation Fund North Holland in 2020.\n\nNote: The summary is based on the relevant information about RetinaScope BV and its product RetinaScope Plus.",
    "Summary_cn": "视网膜镜 BV\n\n产品：RetinaScope Plus\n\n- 一款低成本、手持式眼底相机，旨在更好地筛查眼部疾病，尤其是糖尿病视网膜病变、年龄相关性黄斑变性（AMD）和青光眼。\n- 视网膜镜 BV 成立于2018年，作为荷兰增值分销公司 IDCP BV 的分拆公司，目标是通过将糖尿病患者的眼底成像从专科医生转移到全科医生、验光师和视光师，提供更早、更频繁的眼部疾病筛查。\n- 该公司于2020年获得荷兰应用科学研究院（TNO）和北荷兰创新基金的投资。"
}